Clover Health Investments, Corp.

Clover Health Investments, Corp.

4.95
USD
-0.01
(-0.20%)
-0.03EPS
2.77BMarket Cap
Mar 04Next Earn

Total Valuation

USD

As of June 30, 2026, Clover Health Investments, Corp. carries a market capitalization of 2.77B, placing it among publicly traded companies globally. Its enterprise value stands at 2.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.77B
Enterprise Value2.53B

Important Dates

Clover Health Investments, Corp.'s next confirmed earnings release is scheduled for March 4, 2027.

Earnings Date3/4/2027

Share Statistics

As of June 30, 2026, Clover Health Investments, Corp. has 529.15M shares outstanding.

Shares Outstanding529.15M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 1.10, and the price-to-book ratio stands at 7.37.

PS Ratio1.10
PB Ratio7.37
P/TBV Ratio7.43
P/FCF Ratio37.21
P/OCF Ratio35.31

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 1.02 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.53B versus a market cap of 2.77B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.02

Financial Position

As of June 30, 2026, Clover Health Investments, Corp. maintains a current ratio of 1.50, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

Current Ratio1.50
Quick Ratio1.38

Financial Efficiency

USD

Over the twelve months ended June 30, 2026, Clover Health Investments, Corp. posted a negative return on equity (ROE) of -5.10, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -2.84, reflecting losses generated across the asset base. The company generates approximately 3.61M in revenue per employee across its workforce of 685.50, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-5.10
Return on Assets (ROA)-2.84
Revenue Per Employee3.61M
Employee Count685.50

Stock Price Statistics

USD

As of the close on November 16, 2026, Clover Health Investments, Corp.'s stock has gained approximately 100.40% over the past 52 weeks. The 50-day moving average sits at 4.62, while the 200-day moving average is 3.67.

52-Week Price Change100.40%
50-Day Moving Average4.62
200-Day Moving Average3.67

Income Statement

USD

Over the twelve months ended June 30, 2026, Clover Health Investments, Corp. generated 2.48B in revenue and converted that into -18.36M in net income, yielding earnings per share of -0.03. EBITDA reached -16.46M, while operating income came in at -18.36M.

Revenue2.48B
Gross Profit459.93M
Operating Income-18.36M
Pretax Income-18.36M
Net Income-18.36M
EBITDA-16.46M
EBIT-18.36M
Earnings Per Share (EPS)-0.03

Balance Sheet

USD

These figures are as of June 30, 2026. Total book value stands at 376.26M, with working capital of 162.12M providing operational flexibility.

Cash & Cash Equivalents243.10M
Net Debt-198.84M
Equity (Book Value)376.26M
Book Value Per Share0.71
Working Capital162.12M

Cash Flow

USD

Clover Health Investments, Corp. produced 77.03M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2.82M in capital expenditures, free cash flow totaled 74.21M - equivalent to 0.14 per share.

Operating Cash Flow77.03M
Capital Expenditures-2.82M
Free Cash Flow74.21M
FCF Per Share0.14

Margins

Over the twelve months ended June 30, 2026, Clover Health Investments, Corp. posted a gross margin of 18.57, reflecting its pricing power and cost economics. The operating margin of -0.74 and net profit margin of -0.74 provide insight into operational efficiency.

Gross Margin18.57
Operating Margin-0.74
Pretax Margin-0.74
Profit Margin-0.74
EBITDA Margin-0.66

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 2.69, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.77, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Clover Health Investments, Corp. shareholders.

Shareholder Yield0.77
FCF Yield2.69

Scores

As of June 30, 2026, Clover Health Investments, Corp. has an Altman Z-Score of 4.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.12